Results 121 to 130 of about 19,478 (225)

Rituximab for managing acquired hemophilia A in a case of chronic neutrophilic leukemia with the JAK2 kinase V617F mutation

open access: yesJournal of Blood Medicine, 2012
Shinsaku Imashuku,1 Naoko Kudo,1 Kagekatsu Kubo,1 Katsuyasu Saigo,1 Nanako Okuno,2 Kaoru Tohyama21Division of Hematology, Takasago-seibu Hospital, Takasago, Japan; 2Department of Laboratory Medicine, Kawasaki Medical School, Kurashiki, JapanBackground ...
Okuno N   +5 more
doaj  

Diagnostics of congenital and acquired hemorrhagic diseases in patients with isolated prolonged activated partial thromboplastin time using laboratory algorithm [PDF]

open access: yes, 2016
З метою розроблення алгоритму лабораторної діагностики розладів коагуляційного гемостазу і встановлення причини підвищеної схильності до кровотеч у 61 хворого з геморагічним синдромом було виконано скринінгові, 2 групи корекційних тестів (замінні проби ...
Красівська, В.В.   +1 more
core  

Acquired Hemophilia

open access: yesInternal Medicine, 2015
Kenji, Kimura   +3 more
openaire   +3 more sources

Postpartum Acquired Hemophilia

open access: yesNihon Naika Gakkai Zasshi, 2007
Takeshi, Miyahira   +3 more
openaire   +3 more sources

Acquired Hemophilia presenting as Gross hematuria following Kidney Stone – A case report and review of the literature

open access: yesInternational Brazilian Journal of Urology
A rare condition in itself, acquired hemophilia A, seldom presents as isolated gross hematuria. It is a serious condition with a high mortality rate and thus clinical suspicion followed by prompt diagnosis is imperative (1). In fact, only 8 cases of such
Max Schmidt-Bowman   +5 more
doaj   +1 more source

Technological Discontinuities and the Comparative Strategic Value of New Capabilites: Evidence from the Comparison of Small- and Large-Molecule Targeted Anti-Cancer Drug Discovery [PDF]

open access: yes
Traditional creative destruction theories distinguish disruptions as competence-destroying or competence-enhancing to incumbents’ capabilities, with the former case resulting in incumbents’ loss of competitive advantage in in-house R&D performance (even ...
M. Lourdes Sosa
core  

Home - About - Disclaimer - Privacy